Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Motilal Oswal Securities Ltd.
$58.00
Provider: Axis Capital Limited
$35.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

GlaxoSmithKline Pharmaceuticals Ltd Recommends Dividend


Tuesday, 19 Feb 2013 03:18am EST 

GlaxoSmithKline Pharmaceuticals Ltd announced that the Board of Directors of the Company at its meeting held on February 19, 2013, inter alia, has recommended a Dividend of INR50 per equity shares (Previous year : INR45 per equity share).